Top Medical News

Loyda Braithwaite Discusses Evolving Treatment Options in HR+ Breast Cancer

May 15th 2022

Loyda E. Braithwaite, MSN, RN, AGPCNP-BC, AOCNP, highlights nursing considerations in prescribing and administering endocrine therapy to patients with HR+ breast cancer.

Entrectinib Generates Favorable Outcomes in NTRK Fusion+ Breast Cancer

May 14th 2022

Entrectinib elicited encouraging responses in patients with breast cancer that harbors NTRK fusions, according to updates from the phase 2 STARTRK-2 trial.

Off-the-Shelf Cervical Cancer Vaccine Shows Promising Initial Results in HPV16+ Patients

May 13th 2022

Atezolizumab in conjunction with VB10.16, the first off-the-shelf therapeutic cancer vaccine, elicited encouraging responses in pretreated patients with HPV16-positive advanced cervical cancer.

Cabozantinib/Nivolumab Showcases Clinical Benefit in Papillary Non–Clear Cell RCC

May 13th 2022

Phase 2 trial findings indicate that cabozantinib plus nivolumab may be effective in treating patients with non-clear cell renal cell carcinoma with papillary histology.

Investigational RNA Interference Therapy, ARO-HIF2, Yields Encouraging Phase 1 Results in Clear Cell RCC

May 12th 2022

Patients with clear cell renal cell carcinoma experienced reduced levels of hypoxia inducible factor-2 alpha expression following treatment with ARO-HIF2.


Most Recent